News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Policy
US Court Denies Wyeth (JOBS) Bid to Halt Zosyn Generic-India’s Orchid Chemicals & Pharmaceuticals Ltd.
September 24, 2009
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
Reuters -- India's Orchid Chemicals said on Thursday a U.S. court had denied Wyeth's motion for a temporary restraining order on the sale of its generic version of the Zosyn antibiotic.
Twitter
LinkedIn
Facebook
Email
Print
Legal
MORE ON THIS TOPIC
FDA
US government launches AI-driven programs to overhaul clinical trials
October 1, 2026
·
4 min read
·
Gabrielle Masson
Legal
Nektar prevails in legal battle with Lilly over broken rezpeg partnership
September 25, 2026
·
2 min read
·
Annalee Armstrong
China
China’s surging biotech sector represents both competition and lifeline for the US
September 23, 2026
·
8 min read
·
Shawna Williams
China
FDA raises bar for foreign site inspections as China trials surge
September 2, 2026
·
4 min read
·
Heather McKenzie